To activate the JAK/STAT pathway BRCA1 increased the sensitivity of cervical squamous cell carcinoma (CSCC) patients to cisplatin-based CCRT with upregulated expression of STAT1 [54]. This evidence concerns the gene SOAT1 and skin squamous cell carcinoma.